ANTIBODY DRUG CONJUGATES AND BEYOND:The discovery and development of breakthrough targeted therapies for cancer treatment
ANTIBODY DRUG CONJUGATES AND BEYOND:
We are focused on discovering and developing antibody-drug conjugates (ADCs) against novel targets as breakthrough therapeutics for the treatment of advanced stage solid tumors.
Wntrix Inc. is a preclinical-stage biotechnology company aiming to discover and develop novel therapeutics using the antibody drug conjugate (ADC) approach for solid tumors. Wntrix was founded in 2014 at Houston, Texas.